Top Markets
Coin of the day
China Biotech Services Holdings Limited China Biotech Services Holdings Limited

China Biotech Services Holdings Limited

8037
Rank in Stocks #23175
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech... Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
Share Price
$0.07931426
Last synced: 2026-08-21
Market Cap
$77.39M
Change (1 day)
0.81%
Change (1 year)
-49.20%
Country
HK
Trade China Biotech Services Holdings Limited (8037)

Category

P/B ratio for China Biotech Services Holdings Limited (8037)
P/B ratio as of 2026 TTM: 0
According to China Biotech Services Holdings Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for China Biotech Services Holdings Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US